Spectral AI submits CMS NTAP application for DeepView system reimbursement add-on
MDAI•Spectral AI filed an application seeking an add-on Medicare inpatient reimbursement for its DeepView System through the alternative pathway. CMS is expected to issue a final decision in August 2027; if granted, NTAP status would begin in October 2027.
1. Application and timeline
Spectral AI filed an NTAP application with CMS for its DeepView System, seeking add-on Medicare inpatient reimbursement through the alternative pathway. CMS is expected to issue a final decision in August 2027, with NTAP status starting in October 2027 if granted. DeepView received FDA De Novo classification in May 2026 for AI-based, non-invasive burn-wound healing assessment.
